Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade-Reference-Cited by-同舟云学术

Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

Published:2014-04-29 Issue:7 Volume:2 Page:643-654
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Cooper Zachary A.,Juneja Vikram R.,Sage Peter T.,Frederick Dennie T.,Piris Adriano,Mitra Devarati,Lo Jennifer A.,Hodi F. Stephen,Freeman Gordon J.,Bosenberg Marcus W.,McMahon Martin,Flaherty Keith T.,Fisher David E.,Sharpe Arlene H.,Wargo Jennifer A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-sensitive PD-L1 siRNA cationic selenide nanogels for self-inhibition of autophagy and prevention of immune escape;Bioactive Materials;2024-11

2. Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF^V600E colorectal cancer;Cancer Science;2024-08-22

3. Lung Microbiome Intervention Attenuates Herpesvirus-Induced Post-HCT Pulmonary Fibrosis Through PD-L1 Upregulation on Dendritic Cells;2024-07-10

4. Protective effects of bioactive components targeting β2-adrenergic receptors and muscarinic-3 acetylcholine receptor in Zhisou San on ovalbumin-induced allergic asthma;Journal of Asian Natural Products Research;2024-06-14

5. Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers;Cancer Cell International;2024-05-31